| 1. An implantable device, comprising:
at least one pulse generator adapted to deliver a first electrical signal through at least one electrode positioned proximate
to a vagus nerve and to deliver a second electrical signal through at least one electrode positioned within or proximate to
the heart; and
a controller adapted to communicate with the at least one pulse generator, the controller including a module to provide epilepsy
therapy that includes delivering the first electrical signal though the at least one electrode proximate to the vagus nerve
and a module to provide a cardiac rhythm management (CRM) therapy that includes delivering the second electrical signal through
at least one electrode positioned within or proximate to the heart, the CRM therapy including at least one therapy selected
from an antitachycardia therapy and a cardiac resynchronization therapy (CRT), wherein the CRT is adapted to electrically
stimulate myocardial tissue to coordinate contractions of contralateral cardiac chambers.
|